Global Dermatological Therapeutics Market Size & Growth Analysis Report, 2019-2025
The global dermatological therapeutics market is expected to grow at a significant CAGR during the forecast period. The key factor that drives the global dermatological therapeutics industry includes the rising geriatric population and continuous contributions by the key players.
The aging population is projected to increase with a significant
growth rate during the forecast period. According to WHO, the geriatric
population is going to be double in 2050 as compared to 2000. In 2000, at the
global level,the proportion of the population over 65 years was 11% which is
expected to be 22% by 2050. The geriatric population is expected to reach 2
billion by 2050 as compared to 605 million in 2010. Similarly, the number of geriatric
populations over 80 years or older will be almost quadrupled to 395 million
from 2000 to 2050. As the geriatric population is more prone to diseases due to
low resistance to illness along with reduced skin strength and elasticity.
Thus, this is likely to create the scope for market growth.
To Request a Sample of our Report on Global
Dermatological Therapeutics Market: https://www.omrglobal.com/request-sample/dermatological-therapeutics-market
Further, the key players operating in the global dermatological
therapeutics market is also driving the growth. Players such as AbbVie Inc.,
Allergan PLC., Amgen Inc., Johnson & Johnson Services Inc., Novartis
International AG,Eli Lilly & Co., and LEO Pharma A/S are significantly
contributing to the market growth by adopting various growth strategies.
Product launches & developments, partnerships, agreements, and acquisitions
are among some of the strategies adopted by the players to sustain in a
competitive dermatological therapeutics market during the forecast period.
In November 2018, Sanofi in partnership with Denali Therapeutics
Inc., a biopharmaceutical company, developed DNL758 and DNL747, for the
treatment of a wide range of systemic inflammatory and neurological disorders.
Additionally, Sanofi agreed to invest $125 million to the company regarding the
study and R&D of DNL758 in systemic inflammatory diseases, such as
rheumatoid arthritis and psoriasis and DNL747 in multiple sclerosis,
Alzheimer's disease, and amyotrophic lateral sclerosis.
In July 2018, Novartis International AG signed a licensing
agreement with MorphoSys AG and Galapagos NV, for the compound MOR106. Under
the agreement, Novartis agreed to invest $110.6 million to both the companies
for the acquisition of the exclusive global development and marketing rights to
MOR106 for atopic dermatitis and all other potential indications.
(Get 15% Discount on Buying this Report)
A full
Report of Global Dermatological Therapeutics Market is Available
at: https://www.omrglobal.com/industry-reports/dermatological-therapeutics-market
Global Dermatological Therapeutics Market – Segmentation
By Drug Class
- Anti-infectives
- Corticosteroids
- Calcineurin Inhibitors
- Retinoids
- Others
By Application
- Alopecia
- Herpes
- Psoriasis
- Rosacea
- Atopic Dermatitis
- Metastatic Malignant Melanoma
- Others
Global Dermatological Therapeutics Market – Segmentation by
Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
·
AbbVie
Inc.
·
Aclaris
Therapeutics, Inc.
·
Allergan
PLC
·
Almirall
SA
·
Amgen
Inc.
·
Aurobindo
Pharma Ltd.
·
Bausch
Health Companies Inc.
·
Cipher
Pharmaceuticals Inc.
·
Eli
Lilly & Co.
·
Galderma
SA
·
GlaxoSmithKline
PLC
·
Glenmark
Pharmaceuticals Ltd.
·
Johnson
& Johnson Services Inc.
·
LEO
Pharma A/S
·
Novartis
International AG
·
Pfizer
Inc.
·
Sanofi
SA
·
Sun
Pharmaceutical Industries Ltd.
Reasons to Buying
From us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/dermatological-therapeutics-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment